Iain Miller

Iain Miller, PhD, MBA, is a seasoned executive with extensive experience in healthcare and precision medicine. Currently serving as the Chief Executive Officer at Presymptom Health, Iain is focused on developing clinical decision support algorithms and blood tests for early intervention in infection management. Iain also holds the position of Non Executive Director at PicturaBio and previously advised SIME Diagnostics, which is dedicated to advancing acute care tests to combat severe respiratory disease. As the Founder and CEO of Healthcare Strategies Group, Iain provided strategic advisory services and support to emerging med-tech SMEs. Iain's prior roles include CEO at SAW Diagnostics, member of the Technology Appraisal Committee at NICE, and executive positions at GE Healthcare, bioMerieux, and US Genomics. Iain earned an MBA from Edinburgh Business School and a PhD in BioEngineering from the University of Strathclyde, complemented by a B.Sc in physics from the University of Glasgow.